{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:16:27Z","timestamp":1785770187405,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate the safety and feasibility of sleeve resection under Uni-VATS following neoadjuvant chemotherapy combined with immunotherapy for locally advanced central-type non-small cell lung cancer(NSCLC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We analyzed 10 cIIB-IIIB NSCLC patients who underwent sleeve lung resection under single-port thoracoscopy from December 2022 to August 2023 after receiving platinum-based chemotherapy combined with albumin paclitaxel and programmed cell death protein-1 (PD-1) inhibitor drugs. Perioperative clinical data, side effects during neoadjuvant therapy, operation time, intraoperative blood loss, conversion rate to open thoracotomy, postoperative duration of chest tube placement, postoperative drainage volume, postoperative complications, and tumor outcomes were recorded.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This study included 10 patients. The preoperative clinical staging distribution was as follows: Stage IIB, 1 case; Stage IIIA, 5 cases; and Stage IIIB, 4 cases. Imaging evaluation after neoadjuvant therapy revealed that none of the patients achieved complete remission, whereas partial remission and stable disease were observed in 7 cases and 3 cases, respectively. All patients successfully underwent surgery, of which 2 patients required conversion to open thoracotomy (conversion rate, 20%) and 8 patients underwent single-port thoracoscopic minimally invasive surgery. Notably, 2 patients underwent sleeve resection of the right upper lobe, 2 patients underwent sleeve resection of the right middle and lower lobes, 2 patients underwent sleeve resection of the left upper lobe, and 4 patients underwent sleeve resection of the left lower lobe. The average operation time was 236\u2009\u00b1\u200987.7\u00a0min, the average intraoperative blood loss was 168\u2009\u00b1\u200962.5 mL, the average duration of chest tube placement was 5 days, the average total drainage volume was 1012\u2009\u00b1\u2009464 mL, and the average hospitalization duration was 7 days. One patient developed encapsulated pleural effusion after surgery and underwent computed tomography (CT)-guided puncture drainage. At the 3-month and 6-month follow-up visits, no patient reported any particular discomfort, and chest radiography and CT revealed no abnormalities or signs of tumor recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Sleeve resection after neoadjuvant chemotherapy combined with immunotherapy for locally advanced central-type NSCLC under single-port thoracoscopy is safe and feasible and provides short-term postoperative benefits for patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12957-024-03462-x","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:25:42Z","timestamp":1741933542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of the safety and feasibility of sleeve resection under UniVATS after neoadjuvant chemotherapy combined with immunotherapy for locally advanced central-type non-small cell lung cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Bo","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Yong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"10299","key":"3462_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(21)00312-3","volume":"398","author":"AA Thai","year":"2021","unstructured":"Thai AA, Solomon BJ, Sequist LV, Gainor JF, Heist RS. Lung cancer. Lancet. 2021;398(10299):535\u201354. https:\/\/doi.org\/10.1016\/S0140-6736(21)00312-3. Epub 2021 Jul 21. PMID: 34273294.","journal-title":"Lancet"},{"issue":"13","key":"3462_CR2","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin A, Le Pechoux C, Rolland E, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer[. J] J Clin Oncol. 2010;28(13):2181\u201390. https:\/\/doi.org\/10.1200\/JCO.2009.26.2543.","journal-title":"J] J Clin Oncol"},{"key":"3462_CR3","doi-asserted-by":"publisher","unstructured":"Jonas DE, Reuland DS, Reddy SM et al. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force[J] JAMA, 325(10):971\u201387https:\/\/doi.org\/10.1001\/jama.2021.0377.","DOI":"10.1001\/jama.2021.0377"},{"key":"3462_CR4","doi-asserted-by":"publisher","unstructured":"Potter AL, Rosenstein AL, Kiang MV et al. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study[J].BMJ, 2022, 376.https:\/\/doi.org\/10.1136\/bmj-2021-069008.","DOI":"10.1136\/bmj-2021-069008"},{"key":"3462_CR5","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2017.04.011","volume":"12","author":"K Chansky","year":"2017","unstructured":"Chansky K, Detterbeck FC, Nicholson AG, et al. The IASLC Lung Cancer Staging Project: external Validationof the revision of the TNM Stage groupings in the EighthEdition of the TNM classification of Lung Cancer. JThorac Oncol. 2017;12:1109\u201321.","journal-title":"JThorac Oncol"},{"issue":"6","key":"3462_CR6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S1470-2045(20)30140-6","volume":"21","author":"CA Shu","year":"2020","unstructured":"Shu CA, Gainor JF, Awad MM, et al. Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol. 2020;21(6):786\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(20)30140-6.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3462_CR7","doi-asserted-by":"publisher","first-page":"e600","DOI":"10.1097\/SLA.0000000000005233","volume":"275","author":"H Deng","year":"2022","unstructured":"Deng H, Liu J, Cai X, et al. Radical minimally invasive surgery after Immuno-chemotherapy in initially-unresectable stage IIIB non-small cell lung Cancer. Ann Surg. 2022;275(3):e600\u20132. https:\/\/doi.org\/10.1097\/SLA.0000000000005233.","journal-title":"Ann Surg"},{"issue":"5","key":"3462_CR8","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jtho.2020.01.017","volume":"15","author":"S Gao","year":"2020","unstructured":"Gao S, Li N, Gao S, et al. Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC. J Thorac Oncol. 2020;15(5):816\u201326. https:\/\/doi.org\/10.1016\/j.jtho.2020.01.017.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"3462_CR9","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.21037\/tlcr-2020-63","volume":"9","author":"W Liang","year":"2020","unstructured":"Liang W, Cai K, Chen C, et al. Expert consensus on neoadjuvant immunotherapy for non-small cell lung cancer. Transl Lung Cancer Res. 2020;9(6):2696\u2013715. https:\/\/doi.org\/10.21037\/tlcr-2020-63.","journal-title":"Transl Lung Cancer Res"},{"issue":"6","key":"3462_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.21037\/tlcr.2019.10.11","volume":"8","author":"Z Li","year":"2019","unstructured":"Li Z, Chen W, Xia M, et al. Sleeve lobectomy compared with pneumonectomy for operable centrally located non-small cell lung cancer: a meta-analysis. Transl Lung Cancer Res. 2019;8(6):775\u201386. https:\/\/doi.org\/10.21037\/tlcr.2019.10.11.","journal-title":"Transl Lung Cancer Res"},{"issue":"6","key":"3462_CR11","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.jtcvs.2020.08.027","volume":"162","author":"J Chen","year":"2021","unstructured":"Chen J, Soultanis KM, Sun F, et al. Outcomes of sleeve lobectomy versus pneumonectomy: a propensity score-matched study. J Thorac Cardiovasc Surg. 2021;162(6):1619\u2013e16284. https:\/\/doi.org\/10.1016\/j.jtcvs.2020.08.027.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"3462_CR12","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.athoracsur.2017.03.038","volume":"104","author":"JE Chaft","year":"2017","unstructured":"Chaft JE, Hellmann MD, Velez MJ, Travis WD, Rusch VW. Initial experience with Lung Cancer Resection after Treatment with T-Cell checkpoint inhibitors. Ann Thorac Surg. 2017;104(3):e217\u20138. https:\/\/doi.org\/10.1016\/j.athoracsur.2017.03.038.","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"3462_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.21037\/tlcr-20-778","volume":"10","author":"H Liang","year":"2021","unstructured":"Liang H, Yang C, Gonzalez-Rivas D, et al. Sleeve lobectomy after neoadjuvant chemoimmunotherapy\/chemotherapy for local advanced non-small cell lung cancer. Transl Lung Cancer Res. 2021;10(1):143\u201355. https:\/\/doi.org\/10.21037\/tlcr-20-778.","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"3462_CR14","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/ejcts\/ezx406","volume":"53","author":"S Yendamuri","year":"2018","unstructured":"Yendamuri S, Groman A, Miller A, et al. Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2018;53(3):656\u201363. https:\/\/doi.org\/10.1093\/ejcts\/ezx406.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"9","key":"3462_CR15","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jtho.2016.06.028","volume":"11","author":"FC Detterbeck","year":"2016","unstructured":"Detterbeck FC, Chansky K, Groome P, et al. The IASLC Lung Cancer Staging Project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM classification of Lung Cancer. J Thorac Oncol. 2016;11(9):1433\u201346. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.028.","journal-title":"J Thorac Oncol"},{"key":"3462_CR16","doi-asserted-by":"publisher","unstructured":"Santambrogio L, Cioffi U, De Simone M, Rosso L, Ferrero S, Giunta A. Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report. Chest. 2002;121(2):635-6. https:\/\/doi.org\/10.1378\/chest.121.2.635. PMID: 11834681.","DOI":"10.1378\/chest.121.2.635"},{"key":"3462_CR17","doi-asserted-by":"publisher","unstructured":"Deng HY, Qiu XM, Zhu DX, et al. Video-assisted thoracoscopic sleeve lobectomy for centrally located non-small cell lung Cancer: a Meta-analysis[J]. World J Surg. 2020;45(4). https:\/\/doi.org\/10.1007\/s00268-020-05877-5.","DOI":"10.1007\/s00268-020-05877-5"},{"issue":"9","key":"3462_CR18","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1200\/JCO.2003.11.040","volume":"21","author":"DC Betticher","year":"2003","unstructured":"Betticher DC, Hsu Schmitz SF, T\u00f6tsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol. 2003;21(9):1752\u20139. https:\/\/doi.org\/10.1200\/JCO.2003.11.040.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3462_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41698-020-00135-2","volume":"4","author":"Y Ling","year":"2020","unstructured":"Ling Y, Li N, Li L, et al. Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodes. NPJ Precis Oncol. 2020;4(1):32. https:\/\/doi.org\/10.1038\/s41698-020-00135-2. Published 2020 Dec 1.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"3462_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/cam4.4889","volume":"12","author":"B Zhang","year":"2023","unstructured":"Zhang B, Xiao H, Pu X, et al. A real-world comparison between neoadjuvant chemoimmunotherapy and chemotherapy alone for resectable non-small cell lung cancer. Cancer Med. 2023;12(1):274\u201386. https:\/\/doi.org\/10.1002\/cam4.4889.","journal-title":"Cancer Med"},{"key":"3462_CR21","doi-asserted-by":"publisher","unstructured":"Yuan P, Guo C, Li L, Ling Y, Guo L, Ying J. Immune-related histologic phenotype in pretreatment tumour biopsy predicts the efficacy of neoadjuvant anti-PD-1 treatment in squamous lung cancer. BMC Med. 2022;20(1):403. Published 2022 Oct 24. https:\/\/doi.org\/10.1186\/s12916-022-02609-5.","DOI":"10.1186\/s12916-022-02609-5"},{"issue":"2","key":"3462_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.21037\/tlcr-22-56","volume":"11","author":"J Dai","year":"2022","unstructured":"Dai J, Zhu X, Li D, et al. Sleeve resection after neoadjuvant chemoimmunotherapy in the treatment of locally advanced non-small cell lung cancer. Transl Lung Cancer Res. 2022;11(2):188\u2013200. https:\/\/doi.org\/10.21037\/tlcr-22-56.","journal-title":"Transl Lung Cancer Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-024-03462-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-024-03462-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:25:44Z","timestamp":1741933544000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-024-03462-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3462"],"URL":"https:\/\/doi.org\/10.1186\/s12957-024-03462-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"27 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Affiliated Hospital of North Sichuan Medical College.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}